Literature DB >> 12163168

Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.

Sebastian Dietz1, Karen Rother, Casimir Bamberger, Hartwig Schmale, Joachim Mössner, Kurt Engeland.   

Abstract

The p53 tumor suppressor acts as a transcription factor and has a central function in controlling apoptosis. With p63 and p73 two genes coding for proteins homologous to p53 have been identified. We describe the properties of seven human p63 and p73 proteins as transcriptional activators of p21WAF1/CIP1 expression and apoptotic inducers in direct comparison to p53 in the same assay systems employing DLD-1-tet-off colon cells. Programmed cell death is detected in cells expressing high levels of p53 and p73alpha. Cells overexpressing TAp63alpha, TAp63gamma, TA*p63alpha, TA*p63gamma, DeltaNp63alpha, and DeltaNp63gamma display low or no detectable apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163168     DOI: 10.1016/s0014-5793(02)03093-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

2.  Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

Authors:  Masood A Shammas; Paola Neri; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Vidit Munshi; Rao Prabhala; Mariateresa Fulciniti; Yu Tzu Tai; Steven P Treon; Raj K Goyal; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

3.  Putative function of TAP63α during endochondral bone formation.

Authors:  Feifei Li; Yaojuan Lu; Ming Ding; Guojun Wu; Satrajit Sinha; Siying Wang; Qiping Zheng
Journal:  Gene       Date:  2012-01-05       Impact factor: 3.688

4.  Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice.

Authors:  Helen A Thomason; Huiqing Zhou; Evelyn N Kouwenhoven; Gian-Paolo Dotto; Gaia Restivo; Bach-Cuc Nguyen; Hayley Little; Michael J Dixon; Hans van Bokhoven; Jill Dixon
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

5.  MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells.

Authors:  Kirsten H Limesand; Kathryn L Schwertfeger; Steven M Anderson
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

6.  Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

Authors:  Abdullah A Osman; David M Neskey; Panagiotis Katsonis; Ameeta A Patel; Alexandra M Ward; Teng-Kuei Hsu; Stephanie C Hicks; Thomas O McDonald; Thomas J Ow; Marcus Ortega Alves; Curtis R Pickering; Heath D Skinner; Mei Zhao; Eric M Sturgis; Merrill S Kies; Adel El-Naggar; Federica Perrone; Lisa Licitra; Paolo Bossi; Marek Kimmel; Mitchell J Frederick; Olivier Lichtarge; Jeffrey N Myers
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

7.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

8.  Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage.

Authors:  Ramakrishna Kommagani; Vandana Payal; Madhavi P Kadakia
Journal:  J Biol Chem       Date:  2007-08-23       Impact factor: 5.157

Review 9.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

10.  deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.

Authors:  Oleksi Petrenko; Alexander Zaika; Ute M Moll
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.